Everence Capital Management Inc Amgen Inc Transaction History

Everence Capital Management Inc

$1.59 Billion
Q3 2024

A detailed history of Everence Capital Management Inc transactions in Amgen Inc stock. As of the latest transaction made, Everence Capital Management Inc holds 15,040 shares of AMGN stock, worth $4.75 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares

15,040

Previous 15,040 -0.0%

Holding current value

$4.75 Million

Previous $4.12 Million 17.62%

% of portfolio

0.31%

Previous 0.29%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $180,012 - $203,075	-704 Reduced 4.47%	15,040 $4.33 Million
Q1 2023 Apr 04, 2023	SELL	$225.79 - $275.2 $377,069 - $459,584	-1,670 Reduced 9.59%	15,744 $3.81 Million
Q4 2022 Jan 31, 2023	SELL	$229.03 - $291.01 $284,913 - $362,016	-1,244 Reduced 6.67%	17,414 $4.57 Million
Q2 2022 Jul 26, 2022	SELL	$230.71 - $256.74 $2,307 - $2,567	-10 Reduced 0.05%	18,658 $4.54 Million
Q1 2022 Apr 11, 2022	BUY	$219.27 - $242.57 $655,617 - $725,284	2,990 Added 19.07%	18,668 $4.51 Million
Q3 2021 Oct 21, 2021	BUY	$212.27 - $248.7 $382,086 - $447,660	1,800 Added 12.97%	15,678 $3.33 Million
Q4 2020 Feb 01, 2021	SELL	$216.38 - $257.67 $307,259 - $365,891	-1,420 Reduced 9.28%	13,878 $3.19 Million
Q3 2020 Feb 01, 2021	BUY	$234.65 - $260.95 $96,206 - $106,989	410 Added 2.75%	15,298 $3.89 Million
Q4 2019 Jan 28, 2020	SELL	$189.21 - $243.2 $141,718 - $182,156	-749 Reduced 4.79%	14,888 $3.59 Million
Q1 2019 May 06, 2019	SELL	$180.87 - $203.88 $54,622 - $61,571	-302 Reduced 1.89%	15,637 $2.97 Million
Q3 2018 Oct 22, 2018	SELL	$185.29 - $208.89 $266,817 - $300,801	-1,440 Reduced 8.29%	15,939 $3.3 Million
Q4 2017 Feb 02, 2018	BUY	$168.79 - $188.59 $83,719 - $93,540	496 Added 2.94%	17,379 $3.02 Million
Q3 2017 Oct 31, 2017	BUY	$167.29 - $191.0 $2.82 Million - $3.22 Million	16,883	16,883 $3.15 Million

Others Institutions Holding AMGN

# of Institutions

3,075

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.28M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Everence Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Everence Capital Management Inc with notifications on news.

Account

Everence Capital Management Inc Amgen Inc Transaction History